Partner Headlines - MDVN

  1. Medivation to Expand Global Oncology Franchise With the Acquisition ...

    GuruFocus
  2. Benzinga's M&A Chatter for Monday August 24, 2015

    Benzinga
  3. Medivation to Expand Global Oncology Franchise With the Acquisition ...

    Benzinga
  4. Benzinga's Top #PreMarket Gainers

    Benzinga
  5. Medivation Voted Three Years in a Row Among Top Workplaces in ...

    GuruFocus
  6. UPDATE: Medivation, Astellas Report Enrollment of First Patients ...

    Benzinga
  7. New Enzalutamide Data in Triple-Negative Breast Cancer Presented ...

    Benzinga
  8. Stocks: A Soft Jump On Jobs Data; WhiteWave, Boeing, NXP Climb

    IBD
  9. Top Drugmaker Profits Mixed

    IBD
  10. Medivation, Jazz Q1 Reports Miss; Regeneron Beats

    IBD
  11. Four Hot Stocks You'll Want To Keep On Your Radar

    IBD
  12. Nasdaq, S&P 500 Hang Tough; Avago, Akorn Big Earnings Winners

    IBD
  13. Medivation Tops Q4 Views On Strong Xtandi Results

    IBD
  14. Stocks Mixed; United Therapeutics Jumps To New High

    IBD
  15. Market Edges Higher, Unfazed By Weak HP Results

    IBD
  16. Market's Resilience Is Noteworthy; More Breakouts Emerge

    IBD
  17. Earnings Scheduled For February 25, 2015

    Benzinga
  18. Stocks Show Small Losses; Merger Talk Lifts Discovery

    IBD
  19. Stocks Quietly Lower; Domino's, Medivation Break Out

    IBD
  20. Wedbush Weighs in on Medivation Following Phase II TERRAIN Study ...

    GuruFocus
  21. Valeant Agrees To Buy Dendreon's Provenge

    IBD
  22. Weekly CEO Sells Highlight: QAD Inc, Orbitz Worldwide Inc, Constellation ...

    GuruFocus
  23. Enzalutamide Phase 2 Terrain Trial Demonstrated Statistically ...

    GuruFocus
  24. J&J Earnings Beat, But Sales, Guidance Miss Estimates

    IBD
  25. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD
  26. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  27. Barclays Analyst Sees Biotech FY15 EPS Growth Outstripping Market

    Benzinga
  28. William Blair's Top BioPharmaceutical Stock Picks for Q1 2015

    GuruFocus
  29. Newly Profitable Medivation Riding High On Drug Sales

    IBD
  30. Chip Stocks, Biotechs Lead Another Nasdaq Rally

    IBD
  31. Major Upgrades And Downgrades In Friday's Market Action

    Benzinga
  32. Medivation Hits High After Q3 Earnings Beat

    IBD
  33. Medivation Hits High After Q3 Earnings Beat

    IBD
  34. Medivation and Astellas Announce Phase 3 Study of Enzalutamide ...

    GuruFocus
  35. J&J Earnings Beat; Olysio Chatter Hits Gilead

    IBD
  36. Consider Medivation for Your Portfolio

    FoxBusiness
  37. Benzinga's Top Downgrades

    Benzinga
  38. Goldman Sachs Downgrades Medivation To Neutral, Shares Drop

    Benzinga
  39. These 3 Biotech Stocks Just Hit New Highs

    Benzinga
  40. Fast Money Halftime Report Final Trade From September 12

    Benzinga
  41. Medivation Eyes Blockbuster As Cancer Drug Gets An OK

    IBD
  42. Stifel Raises Medivation Inc Price Target

    Benzinga
  43. Stocks Hitting 52-Week Highs

    Benzinga
  44. A Few Reasons Why Investors Should Consider Dendreon for Their ...

    GuruFocus
  45. Medivation Cancer Drug Fuels Beat, Swings To Profit

    IBD
  46. Benzinga's Volume Movers

    Benzinga
  47. Medivation Announces Change in Executive Management Team; Dawn ...

    Benzinga
  48. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  49. Aegis Capital Believes Seragon Deal Underscores Value In Medivation

    Benzinga
  50. UPDATE: Stifel Reiterates On Medivation Following Prostate Cancer ...

    Benzinga
  51. Benzinga's Top Upgrades

    Benzinga
  52. US Stock Futures Flat Ahead Of International Trade Data

    Benzinga
  53. UPDATE: Canaccord Genuity Initiates Coverage on Medivation as ...

    Benzinga
  54. Morning Market Movers

    Benzinga
  55. Stocks To Watch For April 1, 2014

    Benzinga
  56. Celegene, Pharmacyclics Lead Biotech Short Interest Trend (CELG, ...

    Benzinga
  57. UPDATE: Astellas Announces Marketing Approval in Japan for XTANDI® ...

    Benzinga
  58. BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, ...

    Benzinga
  59. Market Wrap For February 28: Markets Unable To Hold On To Gains

    Benzinga
  60. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE ...

    Benzinga
  61. Benzinga's Top #PreMarket Losers

    Benzinga
  62. 2 Deaths, 25% Plunge -- And Still A Big Upside

    YCharts
  63. Mid-Afternoon Market Update: Fed Will Continue the Taper in February

    Benzinga
  64. Mid-Day Market Update: Yahoo! Slips After Q4 Results; RF Micro ...

    Benzinga
  65. New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN)

    Benzinga
  66. Mid-Morning Market Update: Markets Open Lower; Dow Chemical Posts ...

    Benzinga
  67. Stocks Hitting 52-Week Highs

    Benzinga
  68. Benzinga's Top #PreMarket Gainers

    Benzinga
  69. Medivation and Astellas Announce Final Results From the Phase ...

    Benzinga
  70. UPDATE: Aegis Capital Reiterates on Medivation Following In-Line ...

    Benzinga
  71. Medivation, Astellas Announce Phase 3 PREVAIL Trial of Enzalutamide ...

    Benzinga
  72. Uh Oh: Is This Cancer Highflyer In Your Account?

    YCharts
  73. Worse-Than-Expected Xtandi Sales Hitting Shares of Medivation; ...

    Benzinga
  74. Medivation Elects Kathryn Falberg to Board of Directors

    Benzinga
  75. Medivation Bulls Load Up on Call Options

    SchaeffersResearch
  76. Aegis Capital Corp. Reiterates Buy Rating, $100 PT on Medivation

    Benzinga
  77. Medivation, Inc. (MDVN) President and CEO David Hung sells 1 ...

    GuruFocus
  78. Benzinga's Top Initiations

    Benzinga
  79. Celgene, Regeneron Pharmaceutical Lead Biomed Group

    IBD
  80. Medivation Inc. (MDVN) Chief Business Officer and CFO Clarence ...

    GuruFocus
  81. UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Medivation

    Benzinga
  82. Medivation Effects 2-for-1 Stock Split

    Benzinga
  83. Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)

    Benzinga
  84. US FDA Approves XTANDI for Patients With Metastatic Castration-Resistant ...

    Benzinga
  85. Medivation Reports 2-for-1 Forward Split of Common Stock

    Benzinga
  86. Andreas Halvorsen Buys 2 Million Shares of Medivation

    GuruFocus
  87. Medivation Inc. (MDVN) President and CEO David Hung sells 25, ...

    GuruFocus
  88. Medivation Inc. (MDVN) Chief Business Officer and CFO Clarence ...

    GuruFocus
  89. Stocks Hitting 52-Week Highs

    Benzinga
  90. Health Care Sector Wrap

    FoxBusiness
  91. Four Winning Trades Based on Analyst Calls

    Benzinga
  92. Medivation Bull Looks to Cash In on Continued Rally

    SchaeffersResearch
  93. Analyst Upgrades: MDVN, SCHN, and STI

    SchaeffersResearch
  94. UPDATE: Wedbush Reiterates Outperform Rating, Raises PT for Medivation

    Benzinga
  95. Citigroup Reiterates Buy Rating, $129 PT for Medivation

    Benzinga
  96. Medivation and Astellas Announce Enzalutamide Data

    Benzinga
  97. Crazy Action in Medivation After Negative StreetSweeper Post

    Benzinga
  98. Global Fears and Small Caps: How Much of an Impact?

    Benzinga
  99. Social Media Outlook for Tuesday 15 (DKS, MDVN, BBY, ACOM)

    Benzinga
  100. GlaxoSmithKline, Vertex Point To Biotech Strength

    IBD
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!